Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Zura Bio Ltd changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 41 | 44 | +3 |
| Shares | 14.1M | 15.2M | +1.04M (+7.3%) |
| Value | $93.3M | $70.7M | −$22.6M (−24.2%) |
New holders (10)
Institutions that held Zura Bio Ltd at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 77,999 | $324.8K | 0.00% |
| Atom Investors LP | 46,268 | $216.1K | 0.04% |
| Two Sigma Investments, LP | 32,486 | $151.7K | 0.00% |
| Nuveen Asset Management, LLC | 23,657 | $110.5K | 0.00% |
| Occudo Quantitative Strategies LP | 20,786 | $97.1K | 0.01% |
| Susquehanna International Group, LLP | 12,037 | $56.2K | 0.00% |
| Renaissance Technologies LLC | 11,800 | $55.0K | 0.00% |
| Amundi | 9,929 | $40.3K | 0.00% |
| Meteora Capital, LLC | 28,702 | $2.16K | 0.00% |
| Impact Partnership Wealth, LLC | 200 | $934 | 0.00% |
Sold out (7)
Institutions that held Zura Bio Ltd at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Logos Global Management LP | 424,000 | $2.80M |
| Monashee Investment Management LLC | 240,000 | $1.58M |
| UBS Oconnor LLC | 167,167 | $1.10M |
| Point72 Asset Management, L.P. | 21,100 | $139.3K |
| Lynx1 Capital Management LP | 9,917 | $65.5K |
| IFP Advisors, Inc | 500 | $3.30K |
| Russell Investments Group, Ltd. | 35 | $231 |